Tremblay, Cécile L <br/><br/>
TAK-652, a novel CCR5 inhibitor, has favourable drug interactions with other antiretrovirals in vitro.  [electronic resource] 

 -  Antiviral therapy  2005 
 - 967-8 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1359-6535 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Retroviral Agents--pharmacology<br/>CCR5 Receptor Antagonists<br/>Cells, Cultured<br/>Drug Synergism<br/>HIV-1--drug effects<br/>Imidazoles--pharmacology<br/>Sulfoxides